COPD Trial, Recruiting NCT07199361 Sponsor: Florida International University Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT07199361
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with long-term (chronic) pain in a specific part of the body (peripheral pain) that was caused by an injury or surgery.
  • People between the ages of 19 and 80 years old.
  • People who are currently taking medication to manage their pain.
  • People who have experienced this pain more than once a week for at least three months in a row, based on their own report.

Who may not be able to join:

  • People who have an implanted electronic device in or near the head that is controlled by body signals, such as a deep brain stimulator, cochlear implant, or vagus nerve stimulator.
  • People who have metal implants in their head or within about 30 cm of the treatment device, such as aneurysm clips, stents, implanted electrodes, or bullet fragments. (Note: standard dental fillings are considered acceptable.)
  • People who have an active infection, as this can affect certain blood cells involved in the study.
  • People whose urine drug test comes back positive for a range of substances listed in the trial criteria (confirm with trial site for the full list).
  • People taking any medications other than pain medications, unless those medications have been taken consistently for at least 60 days before joining the trial. People using methadone or buprenorphine specifically to treat opioid addiction would not be eligible.
  • People who have a systemic autoimmune condition such as rheumatoid arthritis or lupus.
  • People who have significant muscle wasting (cachexia) or are assessed as severely frail based on a specific health scoring tool.
  • People with uncontrolled high blood pressure (above 140/90) or who have heart or artery disease.
  • People with poorly managed diabetes, based on a blood sugar level test result above a certain threshold.
  • People with a neurological condition such as Parkinson's disease or multiple sclerosis.
  • People who have been hospitalised for a serious psychiatric condition within the past 12 months, or who are currently experiencing thoughts of suicide.
  • People whose thinking or memory difficulties would make it hard to understand and follow the study procedures, as assessed by a standard cognitive screening test.
  • People who are pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Saurabh Aggarwal, MD., PhD, Florida International University

Phone: 305-348-9634

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Florida International University
Registry
ClinicalTrials.gov
Start date
24 March 2025
Est. completion
25 January 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Pressure Pain Assessment; Thermal (Heat) pain; Thermal (Cold) Pain; Temporal Heat Summation; Conditioned Pain Modulation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov